Skip Navigation LinksHome > March 15, 2014 - Volume 97 - Issue 5 > Extended Spectrum β-Lactamase–Producing Enterobacteriaceae I...
doi: 10.1097/01.TP.0000436928.15650.59
Clinical and Translational Research

Extended Spectrum β-Lactamase–Producing Enterobacteriaceae Infection in Heart and Lung Transplant Recipients and in Mechanical Circulatory Support Recipients

Bui, Kevin T.1; Mehta, Seema1; Khuu, Tam H.2; Ross, David3; Carlson, Margrit1; Leibowitz, Matthew R.1; Schaenman, Joanna M.1; Saggar, Rajan3; Lynch, Joseph P. III3; Ardehali, Abbas4; Kubak, Bernard M.1,5

Collapse Box


Background: Extended spectrum β-lactamase (ESBL)–producing gram-negative bacilli are increasingly reported in patients with a variety of risk factors including prior cephalosporin and antibiotic usage, prolonged hospitalizations, existence of comorbid conditions, and critical illness.

Methods: Retrospective review of infections caused by ESBL-producing Enterobacteriaceae was performed in heart transplant (HTx), lung transplant (LTx), and mechanical circulatory support (MCS) device recipients at a large transplant center.

Results: Among 1065 patients transplanted/implanted, the incidence of ESBL-related infections (bacteremia, urinary tract infections, pneumonia, central venous catheter–associated infection, and wound infections) in HTx, LTx, and MCS device recipients was reported at 2.2%, 5.5%, and 10.7%, respectively, caused by ESBL-producing Klebsiella pneumoniae, Escherichia coli, Klebsiella oxytoca, and Citrobacter freundii.

Conclusions: Early detection and adequate duration of therapy for ESBL-producing Enterobacteriaceae in solid organ transplants and MCS device recipients are essential in successful patient outcomes including prevention of recurrent infection.

© 2014 by Lippincott Williams & Wilkins



Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.